Reggie 78
I don’t expect any ex-US royalties to start flowing in 2023. It looks likely that the ROW partner/s will be announced following any favourable FDA decision. As EMA approval, for example, takes on average 12 months, I wouldn’t expect any EU sales to happen before mid-2024.
In addition, if Fragile-X isn’t factored into the valuation calculations, then US$350m is an overstatement of sales milestones. US$350m is the maximum sales milestones payable across all trofinetide indications. It’s likely to be US$165m or less for trofinetide in Rett.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-3152
-
- There are more pages in this discussion • 8,372 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.59 |
Change
0.380(2.50%) |
Mkt cap ! $1.992B |
Open | High | Low | Value | Volume |
$15.51 | $15.82 | $15.46 | $11.26M | 722.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 696 | $15.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.67 | 6942 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 64 | 15.570 |
1 | 320 | 15.510 |
1 | 181 | 15.450 |
1 | 530 | 15.300 |
1 | 2500 | 15.250 |
Price($) | Vol. | No. |
---|---|---|
15.670 | 2340 | 1 |
15.800 | 20 | 1 |
15.810 | 316 | 1 |
15.850 | 800 | 1 |
15.900 | 500 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online